FindTrial
Sign In

Analysis of Clinical Application of Safflower Xiaoyao Tablets: A Retrospective Study Based on Medical Records

Analysis of Clinical Application of Safflower Xiaoyao Tablets: A Retrospective Study Based on Medical Records

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2200055908
Enrollment
Unknown
Registered
2022-01-23
Start date
2022-01-11
Completion date
Unknown
Last updated
2024-07-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None

Interventions

Cases taking Honghua Xiaoyao tablets:None

Sponsors

Tangshan Traditional Chinese Medicine Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. From October 1, 2016 to October 31, 2021, the cases of taking Honghua Xiaoyao tablets for the first time in the research unit or the cases of taking them again at least 30 days after stopping taking them; 2. Follow the doctor's advice and have at least one visit record during taking Honghua Xiaoyao tablets.

Exclusion criteria

Exclusion criteria: 1. Researchers think that the cases that affect the evaluation of the research drugs are not suitable for collection.

Design outcomes

Primary

MeasureTime frame
Disease recovery and changes of examination results before and after medication;Adverse reactions;Characteristics of users;—

Countries

China

Contacts

Public ContactLiu Shujun

Tangshan Traditional Chinese Medicine Hospital

liusj1112006@126.com+86 138 3155 5607

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026